ALPINE IMMUNE SCIENCES, INC. Intellectual Property Contracts & Agreements

6 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement, dated December 20, 2023, between Alpine Immune Sciences Inc. and AbbVie Global Enterprises Ltd. amending the Option and License Agreement, dated June 17, 20
License Agreements
ALPINE IMMUNE SCIENCES, INC.
2024
Letter Agreement, dated April 12, 2022, between Alpine Immune Sciences Inc. and AbbVie Global Enterprises Ltd. amending the Option and License Agreement, dated June 17, 2017, by...
License Agreements
ALPINE IMMUNE SCIENCES, INC.
Biotechnology
2022
Option and License Agreement, dated June 17, 2020, by and between the Company and AbbVie Ireland Unlimited Company
License Agreements
ALPINE IMMUNE SCIENCES, INC.
Biotechnology
DE
2020
License and Research Agreement Amendment No. 2 by and between AIS Operating Co., Inc. and Kite Pharma, Inc., effective as of October 17, 2018
License Agreements
ALPINE IMMUNE SCIENCES, INC.
Biotechnology
2019
License and Research Agreement Amendment No. 1 by and between AIS Operating Co., Inc. and Kite Pharma, Inc., effective as of October 20, 2017
License Agreements
ALPINE IMMUNE SCIENCES, INC.
Biotechnology
2017
License and Research Agreement by and between Alpine Immune Sciences, Inc. and Kite Pharma, Inc., effective as of October 26, 2015
License Agreements
ALPINE IMMUNE SCIENCES, INC.
Biotechnology
CA
2017